|
Q3 2024
|
5 |
153,008 |
PHVS, KURA, SNDX, LYEL
|
13F-HR
|
11/14/2024 |
000110465924118737 |
|
Q2 2024
|
4 |
148,849 |
PHVS, KURA, SNDX, LYEL
|
13F-HR
|
8/13/2024 |
000110465924088863 |
|
Q1 2024
|
5 |
197,913 |
PHVS, KURA, KNTE, SNDX
|
13F-HR
|
5/15/2024 |
000110465924061747 |
|
Q4 2023
|
5 |
197,872 |
PHVS, KURA, KNTE, SNDX
|
13F-HR
|
2/13/2024 |
000110465924019703 |
|
Q3 2023
|
7 |
180,036 |
PHVS, CBAY, ACRS, KURA
|
13F-HR
|
11/13/2023 |
000110465923117291 |
|
Q2 2023
|
7 |
203,401 |
PHVS, LYEL, KNTE, ACRS
|
13F-HR
|
8/11/2023 |
000110465923090055 |
|
Q1 2023
|
8 |
192,724 |
KNTE, PHVS, LYEL, ACRS
|
13F-HR
|
5/12/2023 |
000110465923059498 |
|
Q4 2022
|
8 |
234,124 |
KNTE, ACRS, PHVS, LYEL
|
13F-HR
|
2/13/2023 |
000110465923019778 |
|
Q3 2022
|
8 |
310,955 |
KNTE, LYEL, ACRS, KURA
|
13F-HR
|
11/14/2022 |
000110465922117992 |
|
Q2 2022
|
8 |
371,386 |
KNTE, LYEL, PHVS, ACRS
|
13F-HR
|
8/12/2022 |
000110465922089764 |
|
Q1 2022
|
9 |
357,448 |
KNTE, LYEL, PHVS, ACRS
|
13F-HR
|
5/13/2022 |
000110465922059937 |
|
Q4 2021
|
9 |
486,015 |
KNTE, LYEL, ACRS, PHVS
|
13F-HR
|
2/11/2022 |
000110465922020350 |
|
Q3 2021
|
12 |
679,115 |
KNTE, LYEL, ACRS, PHVS
|
13F-HR
|
11/12/2021 |
000110465921137700 |
|
Q2 2021
|
13 |
739,796 |
KNTE, LYEL, PHVS, ACRS
|
13F-HR
|
8/16/2021 |
000110465921105289 |
|
Q1 2021
|
13 |
834,839 |
KNTE, PHVS, ACRS, KROS
|
13F-HR
|
5/17/2021 |
000110465921067103 |
|
Q4 2020
|
13 |
920,621 |
KNTE, KROS, RLAY, ALXO
|
13F-HR
|
2/16/2021 |
000110465921023083 |
|
Q3 2020
|
15 |
443,450 |
RLAY, NRIX, KROS, KURA
|
13F-HR
|
11/13/2020 |
000110465920124783 |
|
Q2 2020
|
12 |
205,283 |
KROS, CYTK, KURA, FULC
|
13F-HR
|
8/13/2020 |
000110465920094444 |
|
Q1 2020
|
11 |
81,136 |
CYTK, MYOK, FULC, INSM
|
RESTATEMENT
|
5/28/2020 |
000110465920066873 |
|
Q4 2019
|
14 |
231,764 |
Aerie Pharmaceuticals, Inc., MDCO, INSM, CYTK
|
13F-HR
|
2/14/2020 |
000110465920021578 |
|
Q3 2019
|
19 |
309,434 |
TPTX, Aerie Pharmaceuticals, Inc., INSM, MDCO
|
13F-HR
|
11/13/2019 |
000110465919062963 |
|
Q2 2019
|
22 |
353,792 |
TPTX, INSM, ASND, ALEC
|
13F-HR
|
8/13/2019 |
000114420419039332 |
|
Q1 2019
|
16 |
278,257 |
INSM, CBAY, ASND, Biohaven Pharmaceutical Holding Company Ltd.
|
13F-HR
|
5/14/2019 |
000114420419025824 |
|
Q4 2018
|
18 |
217,868 |
Biohaven Pharmaceutical Holding Company Ltd., INSM, MYOK, CBAY
|
13F-HR
|
2/13/2019 |
000114420419007307 |
|
Q3 2018
|
21 |
305,020 |
INSM, MYOK, Biohaven Pharmaceutical Holding Company Ltd., IMMU
|
13F-HR
|
11/13/2018 |
000114420418059272 |
|
Q2 2018
|
17 |
293,368 |
INSM, Biohaven Pharmaceutical Holding Company Ltd., IMMU, MYOK
|
13F-HR
|
8/14/2018 |
000114420418044638 |
|
Q1 2018
|
18 |
241,186 |
INSM, ASND, CBAY, Biohaven Pharmaceutical Holding Company Ltd.
|
13F-HR
|
5/15/2018 |
000114420418028464 |
|
Q4 2017
|
13 |
142,664 |
INSM, ASND, CBAY, IMMU
|
13F-HR
|
2/13/2018 |
000114420418007694 |